Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Masuo, Kazuko ^a  

^a Nucleus Network Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ARGININE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP; GLYCINE; ISOLEUCINE; THREONINE;

ADRENERGIC SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDERED BREATHING;

EID: 82255174532     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/832821     Document Type: Review

References (117)

1. Mokdad A. H., Bowman B. A., Ford E. S., Vinicor F., Marks J. S., Koplan J. P., The continuing epidemics of obesity and diabetes in the United States. Journal of the American Medical Association 2001 286 10 1195 1200 2-s2.0-0035850402 (Pubitemid 33015548)
2. Heidemann C., Boeing H., boeing@dife.de Pischon T., Nöthlings U., Joost H.-G., Schulze M. B., Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. European Journal of Epidemiology 2009 24 6 281 288 10.1007/s10654-009-9338-7
3. Flegal K. M., Graubard B. I., Williamson D. F., Gail M. H., Cause-specific excess deaths associated with underweight, overweight, and obesity. Journal of the American Medical Association 2007 298 17 2028 2037 2-s2.0-35848935201 10.1001/jama.298.17.2028 (Pubitemid 350074800)
4. Ramsey F., Ussery-Hall A., Garcia D., Centers for disease control and prevention (CDC). MMWR Surveillance Summaries 2008 57 1 20
5. Ogden C. L., Fryar C. D., Carroll M. D., Flegal K. M., Advance data from vital and health statics. CDC 2004 347 1 20
6. Mokdad A. H., Serdula M. K., Dietz W. H., Bowman B. A., Marks J. S., Koplan J. P., The spread of the obesity epidemic in the United States, 19911998. Journal of the American Medical Association 1999 282 16 1519 1522 2-s2.0-0032697493 10.1001/jama.282.16.1519 (Pubitemid 29504044)
7. Preis S. R., Hwang S.-J., Coady S., Pencina M. J., D'Agostino R. B., Savage P. J., Levy D., Fox C. S., Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005. Circulation 2009 119 13 1728 1735 2-s2.0-65349085059 10.1161/CIRCULATIONAHA.108.829176
8. Spraul M., Ravussin E., Fontvieille A. M., Rising R., Larson D. E., Anderson E. A., Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. Journal of Clinical Investigation 1993 92 4 1730 1735 2-s2.0-0027360269 (Pubitemid 23304536)
9. Iwashita S., Tanida M., Terui N., Ootsuka Y., Shu M., Kang D., Suzuki M., Direct measurement of renal sympathetic nervous activity in high-fat diet-related hypertensive rats. Life Sciences 2002 71 5 537 546 2-s2.0-0037150766 10.1016/S0024-3205(02)01707-1 (Pubitemid 34607645)
10. Monroe M. B., Seals D. R., Shapiro L. F., Bell C., Johnson D., Jones P. P., Direct evidence for tonic sympathetic support of resting metabolic rate in healthy adult humans. American Journal of Physiology 2001 280 5 E740 E744 2-s2.0-0035010368
11. Blaak E. E., van Baak M. A., Kempen K. P. G., Saris W. H. M., Role of α-and β -adrenoceptors in sympathetically mediated thermogenesis. American Journal of Physiology 1993 264 1 E11 E17 2-s2.0-0027388998 (Pubitemid 23054681)
12. Hagström-Toft E., Enoksson S., Moberg E., Bolinder J., Arner P., β -adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. American Journal of Physiology 1998 275 6 E909 E916 2-s2.0-0032445831
13. Enoksson S., Talbot M., Rife F., Tamborlane W. V., Sherwin R. S., Caprio S., Impaired in vivo stimulation of lipolysis in adipose tissue by selective β 2-adrenergic agonist in obese adolescent girls. Diabetes 2000 49 12 2149 2153 2-s2.0-0033645792
14. Masuo K., Mikami H., Ogihara T., Tuck M. L., Familial hypertension, insulin, sympathetic activity, and blood pressure elevation. Hypertension 1998 32 1 96 100 2-s2.0-0031925914 (Pubitemid 28324131)
15. Masuo K., Mikami H., Ogihara T., Tuck M. L., Familial obesity, sympathetic activation and blood pressure level. Blood Pressure 2001 10 4 199 204 2-s2.0-0035215321 10.1080/08037050152669701 (Pubitemid 33149899)
16. Cui J., Hopper J. L., Harrap S. B., Genes and family environment explain correlations between blood pressure and body mass index. Hypertension 2002 40 1 7 12 2-s2.0-0036314870 10.1161/01.HYP.0000022693.11752.E9 (Pubitemid 34755971)
17. Cui J., Hopper J. L., Harrap S. B., Genes and family environment explain correlations between blood pressure and body mass index. Hypertension 2002 40 1 7 12 2-s2.0-0036314870 10.1161/01.HYP.0000022693.11752.E9 (Pubitemid 34755971)
18. Scurrah K. J., Zaloumis S. G., Hopper J. L., Harrap S. B., Contribution of genes and environment to variation in postural changes in mean arterial and pulse pressure. Journal of Hypertension 2008 26 12 2319 2325 2-s2.0-59849108322 10.1097/HJH.0b013e3283140c89
19. Masuo K., Mikami H., Ogihara T., Tuck M. L., Differences in insulin and sympathetic responses to glucose ingestion due to family history of hypertension. American Journal of Hypertension 1996 9 8 739 745 2-s2.0-0029740993 10.1016/0895-7061(96)00204-X (Pubitemid 26271218)
20. Pereira A. C., Floriano M. S., Mota G. F. A., Cunha R. S., Herkenhoff F. L., Mill J. G., Krieger J. E., β 2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 2003 42 4 685 692 2-s2.0-0141928183 10.1161/01.HYP.0000085648. 65419.17 (Pubitemid 37237310)
21. Masuo K., Katsuya T., Fu Y., Rakugi H., Ogihara T., Tuck M. L., β 2- and β 3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005 111 25 3429 3434 2-s2.0-21544454653 10.1161/CIRCULATIONAHA.104.519652 (Pubitemid 40923396)
22. Masuo K., kmasuo@baker.edu.au Katsuya T., Kawaguchi H., Fu Y., Rakugi H., Ogihara T., Tuck M. L., Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the β 2-adrenoceptor. American Journal of Hypertension 2005 18 11 1508 1516 10.1016/j.amjhyper.2005.05.006 (Pubitemid 41566684)
23. Leineweber K., Beta-adrenergic receptor polymorphism in human cardiovascular disease. Annals of Medicine 2004 36 1 64 69 2-s2.0-2442692712 10.1080/17431380410032544 (Pubitemid 38669926)
24. Jablonskis L. T., Howe P. R. C., Lack of influence of circulating adrenaline on blood pressure in normotensive and hypertensive rats. Blood Pressure 1994 3 1-2 112 119 2-s2.0-0028300324 (Pubitemid 24089521)
25. Dóda M., Role of different subtypes of adrenoceptors in pressor responses to catecholamines released from sympathetic nerve endings. Brain Research Bulletin 1996 42 1 51 57 2-s2.0-0030479722 10.1016/S0361-9230(96)00202- X (Pubitemid 26427621)
26. Ferrannini E., Buzzigoli G., Bonadonna R., Insulin resistance in essential hypertension. The New England Journal of Medicine 1987 317 6 350 357 2-s2.0-0023191508 (Pubitemid 17118813)
27. Masuo K., Mikami H., Ogihara T., Tuck M. L., Prevalence of hyperinsulinemia in young, nonobese Japanese men. Journal of Hypertension 1997 15 2 157 165 2-s2.0-0031044964 10.1097/00004872-199715020-00006 (Pubitemid 27116498)
28. Landsberg L., Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). Journal of Hypertension 2001 19 3 523 528 2-s2.0-0035066361 10.1097/00004872-200103001-00001 (Pubitemid 32280942)
29. Ward K. D., Sparrow D., Landsberg L., Young J. B., Vokonas P. S., Weiss S. T., Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study. Journal of Hypertension 1996 14 3 301 308 2-s2.0-0029967740 10.1097/00004872-199603000-00005 (Pubitemid 26137625)
30. Masuo K., Kawaguchi H., Mikami H., Ogihara T., Tuck M. L., Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003 42 4 474 480 2-s2.0-0141962657 10.1161/01.HYP.0000091371.53502.D3 (Pubitemid 37237341)
31. Masuo K., Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin. Current Hypertension Reports 2002 4 2 112 118 2-s2.0-0036551287
32. Straznicky N. E., Lambert E. A., Lambert G. W., Masuo K., Esler M. D., Nestel P. J., Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 11 5998 6005 2-s2.0-27744591354 10.1210/jc.2005-0961 (Pubitemid 41606517)
33. Landsberg L., Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Quarterly Journal of Medicine 1986 61 236 1081 1090 2-s2.0-0022856921 (Pubitemid 17230168)
34. Landsberg L., Young J. B., Fasting, feeding and regulation of the sympathetic nervous system. The New England Journal of Medicine 1978 298 23 1295 1301 2-s2.0-0017828639 (Pubitemid 8361454)
35. O'Dea K., Esler M., Leonard P., Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism 1982 31 9 896 899 (Pubitemid 12049442)
36. Julius S., Valentini M., Palatini P., Overweight and hypertension: a 2-way street? Hypertension 2000 35 3 807 813 2-s2.0-0034060897 (Pubitemid 30165330)
37. Masuo K., Mikami H., Itoh M., Ogihara T., Tuck M. L., Sympathetic activity and body mass index contribute to blood pressure levels. Hypertension Research 2000 23 4 303 310 2-s2.0-0033921045 (Pubitemid 30444990)
38. Rocchini A. P., Mao H. Z., Babu K., Marker P., Rocchini A. J., Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 1999 33 1 548 553 2-s2.0-0032947371 (Pubitemid 29065718)
39. Valentini M., Julius S., Palatini P., Brook R. D., Bard R. L., Bisognano J. D., Kaciroti N., Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. Journal of Hypertension 2004 22 10 1999 2006 2-s2.0-5044231782 10.1097/00004872-200410000- 00024 (Pubitemid 39336684)
40. Large V., Hellström L., Reynisdottir S., Lönnqvist F., Eriksson P., Lannfelt L., Arner P., Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. Journal of Clinical Investigation 1997 100 12 3005 3013 (Pubitemid 28022837)
41. Stob N. R., Bell C., cbell@cahs.colostate.edu van Baak M. A., Seals D. R., Thermic effect of food and β -adrenergic thermogenic responsiveness in habitually exercising and sedentary healthy adult humans. Journal of Applied Physiology 2007 103 2 616 622 10.1152/japplphysiol.01434.2006 (Pubitemid 47204981)
42. Hayakawa T., Nagai Y., Kahara T., Yamashita H., Takamura T., Abe T., Nomura G., Kobayashi K.-I., Gln27Glu and Arg16Gly polymorphisms of the β 2-adrenergic receptor gene are not associated with obesity in Japanese men. Metabolism 2000 49 9 1215 1218 2-s2.0-0033812163 10.1053/meta.2000.8622
43. Jia H., Sharma P., Hopper R., Dickerson C., Lloyd D. D., Brown M. J., β 2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians. Journal of Hypertension 2000 18 6 687 693 2-s2.0-0033623878 (Pubitemid 30406739)
44. Xie H.-G., Stein C. M., Kim R. B., Gainer J. V., Sofowora G., Dishy V., Brown N. J., Goree R. E., Haines J. L., Wood A. J. J., Human β 2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clinical Pharmacology and Therapeutics 2000 67 6 670 675 2-s2.0-0033623880 (Pubitemid 30416083)
45. Candy G., Samani N., Norton G., Woodiwiss A., Radevski I., Wheatley A., Cockcroft J., Hall I. P., ian.hall@nottingham.ac.uk Association analysis of β 2 adrenoceptor polymorphisms with hypertension in a Black African population. Journal of Hypertension 2000 18 2 167 172 (Pubitemid 30114062)
46. Cockcroft J. R., Gazis A. G., Cross D. J., Wheatley A., Dewar J., Hall I. P., Noon J. P., β 2-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000 36 3 371 375 2-s2.0-0033822323
47. Meirhaeghe A., Helbecque N., Cottel D., Amouyel P., Philippe. Amouvel@pasteur-lille.fr Impact of polymorphisms of the human β 2-adrenoceptor gene on obesity in a French population. International Journal of Obesity 2000 24 3 382 387 (Pubitemid 30137732)
48. Kato N., Sugiyama T., Morita H., Kurihara H., Sato T., Yamori Y., Yazaki Y., Association analysis of β 2-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 2001 37 2 286 292 2-s2.0-0035090301 (Pubitemid 32199089)
49. Bengtsson K., Orho-Melander M., Melander O., Lindblad U., Ranstam J., Råstam L., Groop L., β 2-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 2001 37 5 1303 1308 2-s2.0-0035717657 (Pubitemid 34163586)
50. Ellsworth D. L., Coady S. A., Chen W., Srinivasan S. R., Elkasabany A., Gustat J., Boerwinkle E., Berenson G. S., Influence of the β 2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa heart study. International Journal of Obesity 2002 26 7 928 937 10.1038/sj.ijo.0802020 (Pubitemid 34756174)
51. Kim S.-H., Kim D.-J., Seo I. A., Min Y.-K., Lee M.-S., Kim K.-W., Lee M.-K., Significance of β 2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism 2002 51 7 833 837 2-s2.0-0036634633 10.1053/meta.2002.33347 (Pubitemid 34784806)
52. Chang T.-J., Tsai M.-H., Jiang Y.-D., Lee B., Lee K.-C., Lin J.-Y., Chiu K. C., Tai T.-Y., Chuang L.-M., The Arg16Gly polymorphism of human β 2-adrenoreceptor is associated with type 2 diabetes in Taiwanese people. Clinical Endocrinology 2002 57 5 685 690 2-s2.0-0036425967 10.1046/j.1365-2265. 2002.01661.x (Pubitemid 35316988)
53. Van Rossum C. T. M., Hoebee B., Seidell J. C., Bouchard C., Van Baak M. A., De Groot C. P. G. M., Chagnon M., De Graaf C., Saris W. H. M., Genetic factors as predictors of weight gain in young adult Dutch men and women. International Journal of Obesity 2002 26 4 517 528 10.1038/sj/ijo/0801964 (Pubitemid 34407265)
54. Garenc C., Pérusse L., Chagnon Y. C., Rankinen T., Gagnon J., Borecki I. B., Leon A. S., Skinner J. S., Wilmore J. H., Rao D. C., Bouchard C., Effects of β 2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obesity Research 2003 11 5 612 618 2-s2.0-3343023655 (Pubitemid 41151611)
55. Galletti F., galletti@unina.it Iacone R., Ragone E., Russo O., Della Valle E., Siani A., Barba G., Farinaro E., Strazzullo V., Strazzullo P., Lack of association between polymorphism in the β 2- adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study. American Journal of Hypertension 2004 17 8 718 720 10.1016/j.amjhyper.2004.04.012 (Pubitemid 39091554)
56. Ikarashi T., Hanyu O., Maruyama S., Souda S., Kobayashi C., Abe E., Ukisu J., Naganuma K., Suzuki A., Toya M., Kaneko S., Suzuki K., Nakagawa O., Aizawa Y., Genotype Gly/Gly of the Arg16Gly polymorphism of the β 2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients. Diabetes Research and Clinical Practice 2004 63 1 11 18 2-s2.0-0345730916 10.1016/j.diabres.2003.08.010 (Pubitemid 38018952)
57. Tafel J., Branscheid I., Skwarna B., Schlimme M., Morcos M., Algenstaedt P., Hinney A., Hebebrand J., Nawroth P., Hamann A., andreashamann@med.uni- heidelberg.de Variants in the human β 1-, β 2- and β 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents. Diabetes, Obesity and Metabolism 2004 6 6 452 455 10.1111/j.1462-8902.2004.00366.x (Pubitemid 39409796)
58. Ellsworth D. L., Coady S. A., Chen W., Srinivasan S. R., Boerwinkle E., Berenson G. S., berenson@mailhost.tcs.tulane.edu Interactive effects between polymorphisms in the β -adrenergic receptors and longitudinal changes in obesity. Obesity Research 2005 13 3 519 526
59. Trombetta I. C., Batalha L. T., Rondon M. U. P. B., Laterza M. C., Frazzatto E., Alves M. J. N. N., Santos A. C., Brum P. C., Barretto A. C. P., Halpern A., Villares S. M. F., Negrão C. E., Gly16 + Glu27 β 2-adrenoceptor polymorphisms cause increased forearm blood flow responses to mental stress and handgrip in humans. Journal of Applied Physiology 2005 98 3 787 794 2-s2.0-20044381464 10.1152/japplphysiol.00503.2004 (Pubitemid 40283655)
60. Masuo K., Katsuya T., Fu Y., Rakugi H., Ogihara T., Tuck M. L., β 2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. American Journal of Hypertension 2005 18 7 1009 1014 2-s2.0-22844435290 10.1016/j.amjhyper.2005.01.006 (Pubitemid 41040275)
61. Masuo K., Katsuya T., Kawaguchi H., Fu Y., Rakugi H., Ogihara T., Tuck M. L., β 2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. American Journal of Hypertension 2006 19 10 1084 1091 2-s2.0-33749353201 10.1016/j.amjhyper.2006.02.015 (Pubitemid 44488664)
62. Kawaguchi H., Masuo K., Katsuya T., Sugimoto K., Rakugi H., Ogihara T., Tuck M. L., β 2- and β 3-adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Hypertension Research 2006 29 12 951 959 2-s2.0-33846827079 10.1291/hypres.29.951 (Pubitemid 46206581)
63. Kurabayashi T., Yahata T., Quan J., Tanaka K., Association of polymorphisms in the β 2 and β 3 adrenoceptor gene with polycystic ovary syndrome. Journal of Reproductive Medicine 2006 51 5 389 393 2-s2.0-33646756840 (Pubitemid 43765080)
64. Gjesing A. P., apri@steno.dk Andersen G., Burgdorf K. S., Borch-Johnsen K., Jorgensen T., Hansen T., Pedersen O., Studies of the associations between functional β 2- adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia 2007 50 3 563 568 10.1007/s00125-006-0578-8 (Pubitemid 46215499)
65. Masuo K., Katsuya T., Sugimoto K., Kawaguchi H., Rakugi H., Ogihara T., Tuck M. L., High plasma norepinephrine levels associated with β 2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals. Hypertension Research 2007 30 6 503 511 2-s2.0-34447545508 10.1291/hypres.30.503 (Pubitemid 47083120)
66. Echwald S. M., Sorensen T. I. A., Tybjærg-Hansen A., Andersen T., Pedersen O., Gln27Glu variant of the human β 2-adrenoreceptor gene is not associated with early-onset obesity in Danish men. Diabetes 1998 47 10 1657 1658 2-s2.0-0031685380 10.2337/diabetes.47.10.1657 (Pubitemid 28445358)
67. Hellström L., Large V., Reynisdottir S., Wahrenberg H., Arner P., The different effects of a Gln27Glu β 2-adrenoceptor gene polymorphism on obesity in males and in females. Journal of Internal Medicine 1999 245 3 253 259 2-s2.0-0032998134 10.1046/j.1365-2796.1999.0437e.x (Pubitemid 29132968)
68. Kortner B., Wolf A., Wendt D., Beisiegel U., Evans D., evans@uke.uni-hamburg.de Lack of association between a human β -2 adrenoceptor gene polymorphism (Gln27Glu) and morbid obesity. International Journal of Obesity 1999 23 10 1099 1100 (Pubitemid 29476214)
69. Kawamura T., Egusa G., Fujikawa R., Okubo M., Gln27Glu variant of the β 2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans. Metabolism 2001 50 4 443 446 2-s2.0-0035317077 10.1053/meta.2001.21695 (Pubitemid 32321953)
70. Ukkola O., Tremblay A., Bouchard C., Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. International Journal of Obesity 2001 25 11 1604 1608 10.1038/sj.ijo.0801810 (Pubitemid 33052067)
71. González Sánchez J. L., Proenza A. M., Martínez Larrad M. T., Ramis J. M., Fernández Pérez C., Palou A., Serrano Ríos M., The glutamine 27 glutamic acid polymorphism of the β 2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clinical Endocrinology 2003 59 4 476 481 2-s2.0-0141616466 10.1046/j.1365-2265.2003.01871.x (Pubitemid 37188178)
72. Rasmussen M., Belza A., Almdal T., Toubro SO., Bratholm P., Astrup A., Christensen N. J., Change in β 1-adrenergic receptor protein concentration in adipose tissue correlates with diet-induced weight loss. Clinical Science 2005 108 4 323 329 2-s2.0-17844376785 10.1042/CS20040238 (Pubitemid 40516995)
73. Linné Y., Dahlman I., Hoffstedt J., β 1-adrenoceptor gene polymorphism predicts long-term changes in body weight. International Journal of Obesity 2005 29 5 458 462 2-s2.0-17844374080 10.1038/sj.ijo.0802892 (Pubitemid 40592986)
74. Rydén M., Hoffstedt J., Eriksson P., Bringman S., Arner P., The Arg389gly β 1-adrenergic receptor gene polymorphism and human fat cell lipolysis. International Journal of Obesity 2001 25 11 1599 1603 10.1038/sj.ijo.0801815 (Pubitemid 33052066)
75. Gjesing A. P., apri@steno.dk Andersen G., Albrechtsen A., Glümer C., Borch-Johnsen K., Jorgensen T., Hansen T., Pedersen O., Studies of associations between the Arg389Gly polymorphism of the β 1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabetic Medicine 2007 24 4 392 397 10.1111/j.1464-5491.2006.02031.x (Pubitemid 46452390)
76. Clement K., Vaisse C., Manning B. S. J., Basdevant A., Guy-Grand B., Ruiz J., Silver K. D., Shuldiner A. R., Froguel P., Strosberg A. D., Genetic variation in the β 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. The New England Journal of Medicine 1995 333 6 352 354 2-s2.0-0028978910 10.1056/NEJM199508103330605
77. Widen E., Lehto M., Kanninen T., Walston J., Shuldiner A. R., Groop L. C., Association of a polymorphism in the β 3-adrenergic-receptor gene with features of the insulin resistance syndrome in finns. The New England Journal of Medicine 1995 333 6 348 351 2-s2.0-0028978913 10.1056/NEJM199508103330604
78. Walston J., Silver K., Bogardus C., Knowler W. C., Celi F. S., Austin S., Manning B., Strosberg A. D., Stern M. P., Raben N., Sorkin J. D., Roth J., Shuldiner A. R., Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β 3-adrenergic-receptor gene. The New England Journal of Medicine 1995 333 6 343 347 2-s2.0-0029084088 10.1056/ NEJM199508103330603
79. Fujisawa T., Ikegami H., Yamato E., Takekawa K., Nakagawa Y., Hamada Y., Oga T., Ueda H., Shintani M., Fukuda M., Ogihara T., Association of Trp64Arg mutation of the β 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 1996 39 3 349 352 2-s2.0-9044228020 10.1007/s001250050452 (Pubitemid 26064828)
80. Silver K., Walston J., Wang Y., Dowse G., Zimmet P., Shuldiner A. R., Molecular scanning for mutations in the β 3-adrenergic receptor gene in nauruans with obesity and noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 1996 81 11 4155 4158 2-s2.0-0029821315 10.1210/jc.81.11.4155 (Pubitemid 26380432)
81. Fujisawa T., Ikegami H., Yamato E., Hamada Y., Kamide K., Rakugi H., Higaki J., Murakami H., Shimamoto K., Ogihara T., Trp64Arg mutation of β 3-adrenergic receptor in essential hypertension. Insulin resistance and the adrenergic system. American Journal of Hypertension 1997 10 1 101 105 2-s2.0-0030614767 10.1016/S0895-7061(96)00297-X (Pubitemid 27038978)
82. Sakane N., Yoshida T., Umekawa T., Kondo M., Sakai Y., Takahashi T., β 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 1997 40 2 200 204 10.1007/s001250050663 (Pubitemid 27060293)
83. Rissanen J., Kuopusjärvi M., Pihlajamäki J., Sipiläinen R., Heikkinen S., Vanhala M., Kekäläinen P., Kuusisto J., Laakso M., markku.laakso@uku.fi The Trp64Arg polymorphism of the β 3-adrenergic receptor gene: lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 1997 20 8 1319 1323 (Pubitemid 27318380)
84. McFarlane-Anderson N., Bennett F., Wilks R., Howell S., Newsome C., Cruickshank K., Forrester T., The Trp64Arg mutation of the β 3-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women. Metabolism 1998 47 5 617 621 2-s2.0-0032064234 10.1016/S0026-0495(98)90249-9 (Pubitemid 28213125)
85. García-Rubi E., Starling R. D., Tchernof A., Matthews D. E., Walston J. D., Shuldiner A. R., Silver K., Poehlman E. T., epoehlma/zoo.uvm.edu Calles-Escandón J., Trp64Arg variant of the β 3-adrenoceptor and insulin resistance in obese postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1998 83 11 4002 4005 (Pubitemid 28513587)
86. Janssen J. A. M. J. L., Koper J. W., Stolk R. P., Englaro P., Uitterlinden A. G., Huang Q., Van Leeuwen J. P. T. M., Blum W. F., Attanasio A. M. F., Pols H. A. P., Grobbee D. E., De Jong F. H., Lamberts S. W. J., Lack of associations between serum leptin, a polymorphism in the gene for the β 3-adrenergic receptor and glucose tolerance in the Dutch population. Clinical Endocrinology 1998 49 2 229 234 2-s2.0-15444339759 10.1046/j.1365-2265.1998. 00513.x (Pubitemid 28372653)
87. Shiwaku K., Gao T. Q., Isobe A., Fukushima T., Yamane Y., A Trp64Arg mutation in the β 3-adrenergic receptor gene is not associated with moderate overweight in Japanese workers. Metabolism 1998 47 12 1528 1530 2-s2.0-13144255670 (Pubitemid 28565540)
88. Ongphiphadhanakul B., Rajatanavin R., Chanprasertyothin S., Piaseu N., Chailurkit L., Komindr S., Bunnag P., Puavilai G., Relation of β 3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais. Metabolism 1999 48 5 564 567 2-s2.0-0033125893 10.1016/S0026-0495(99)90051-3 (Pubitemid 29230514)
89. Pulkkinen A., Kareinen A., Saarinen L., Heikkinen S., Lehto S., Laakso M., The codon 64 polymorphism of the β 3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism 1999 48 7 853 856 2-s2.0-0033061280 10.1016/S0026-0495(99)90218-4 (Pubitemid 29310039)
90. Christiansen C., cc@dadlnet.dk Poulsen P., Beck-Nielsen H., The Trp64Arg mutation of the adrenergic β -3 receptor gene impairs insulin secretion: a twin study. Diabetic Medicine 1999 16 10 835 840 10.1046/j.1464-5491.1999.00130. x (Pubitemid 29498222)
91. Stangl K., Cascorbi I., Laule M., Stangl V., Meisel C., Wernecke K.-D., Ziemer S., Baumann G., Roots I., Hauner H., The β 3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease. Metabolism 2001 50 2 184 188 2-s2.0-0035109950 10.1053/meta.2001.20179 (Pubitemid 32170831)
92. Strazzullo P., strazzul@unina.it Iacone R., Siani A., Cappuccio F. P., Russo O., Barba G., Barbato A., D'Elia L., Trevisan M., Farinaro E., Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti prospective heart study. Journal of Hypertension 2001 19 3 399 406 10.1097/00004872-200103000-00007 (Pubitemid 32195375)
93. Ishii T., Hirose H., Kawai T., Hayashi K., Maruyama H., Saito I., Saruta T., Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and β 3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men. Metabolism 2001 50 11 1301 1307 10.1053/meta.2001.27228 (Pubitemid 34007389)
94. Kurokawa N., Nakai K., Kameo S., Liu Z.-M., Satoh H., Association of BMI with the β 3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obesity Research 2001 9 12 741 745 2-s2.0-0035650476 (Pubitemid 33603888)
95. Ochoa M. C., Marti A., amarti@unav.es Azcona C., Chueca M., Oyarzábal M., Pelach R., Patiño A., Moreno-Aliaga M. J., Martínez-González M. A., Martínez J. A., Gene-gene interaction between PPAR γ 2 and ADR β 3 increases obesity risk in children and adolescents. International Journal of Obesity 2004 28 supplement 3 S37 S41 10.1038/sj.ijo.0802803 (Pubitemid 39564315)
96. Porto P. I., García S. I., Dieuzeide G., González C., Landa M. S., Pirola C. J., cjpirola@ciudad.com.ar Clinical features of the metabolic syndrome in adolescents: minor role of the Trp64Arg β 3-adrenergic receptor gene variant. Pediatric Research 2004 55 5 836 841 10.1203/01.PDR.0000119367. 21770.D7 (Pubitemid 38520452)
97. Tsai P.-J., Tsai L.-P., Lee Y.-H., Hsu S.-P., Yang S.-P., Chu C.-H., Yu C.-H., Lack of relationship between β 3-adrenergic receptor gene polymorphism and gestational diabetes mellitus in a Taiwanese population. Metabolism 2004 53 9 1136 1139 10.1016/j.metabol.2004.04.006 (Pubitemid 39140747)
98. Hojlund K., k.hojlund@dadlnet.dk Christiansen C., Bjornsbo K. S., Poulsen P., Bathum L., Henriksen J. E., Lammert O., Beck-Nielsen H., Energy body composition and insulin response to glucose in male twins discordant for the Trp64Arg polymorphism of the β 3 -adrenergic receptor gene. Diabetes, Obesity and Metabolism 2006 8 3 322 330 10.1111/j.1463-1326.2005.00509.x
99. Tamaki S., Nakamura Y., nakamury@kyoto-wu.ac.jp Tabara Y., Okamura T., Kita Y., Kadowaki T., Tsujita Y., Horie M., Miki T., Ueshima H., Relationship between metabolic syndrome and Trp64Arg polymorphism of the β 3-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertension Research 2006 29 11 891 896 10.1291/hypres.29.891 (Pubitemid 46062120)
100. Morcillo S., Cardona F., Rojo-Martínez G., Almaraz M. C., Esteva I., Ruiz-De-Adana M. S., Olveira G., García-Fuentes E., Gómez-Zumaquero J. M., Soriguer F., Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Clinical Endocrinology 2008 68 1 102 107 2-s2.0-36949033371 10.1111/j.1365-2265. 2007.03006.x (Pubitemid 350243489)
101. Gjesing A. P., apri@steno.dk Andersen G., Borch-Johnsen K., Jorgensen T., Hansen T., Pedersen O., Association of the β 3-adrenergic receptor Trp64Arg polymorphism with common metabolic traits: studies of 7605 middle-aged white people. Molecular Genetics and Metabolism 2008 94 1 90 97 10.1016/j.ymgme.2007.12.003
102. Dunajska K., Lwow F., Milewicz A., Jdrzejuk D., aczmaski., Belowska-Bie K., Urban J., Szuba A., β 3-adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women. Gynecological Endocrinology 2008 24 3 133 138 2-s2.0-40549128304 10.1080/09513590801921686 (Pubitemid 351365854)
103. Maxwell T. J., Ameyaw M. M., Pritchard S., Thornton N., Folayan G., Githang'a J., Indalo A., Tariq M., Mobarek A., Evans D. A., Ofori-Adjei D., Templeton A. R., McLeod H. L., Beta-2 adrenergic receptor genotypes and haplotypes in different ethnic groups. International Journal of Molecular Medicine 2005 16 4 573 580
104. Schelleman H., Stricker B. H., b.stricker@erasmusmc.nl De Boer A., Kroon A. A., Verschuren M. W.M., Van Duijn C. M., Psaty B. M., Klungel O. H., Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 2004 64 16 1801 1816 10.2165/00003495-200464160-00006 (Pubitemid 39215190)
105. Hoffstedt J., Poirier O., Thörne A., Lönnqvist F., Herrmann S. M., Cambien F., Arner P., peter.arner@medhs.ki.se Polymorphism of the human β 3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999 48 1 203 205 10.2337/diabetes.48.1.203 (Pubitemid 29019374)
106. Sandilands A., Yeo G., Brown M. J., O'Shaughnessy K. M., kmo22@medschl.cam.ac.uk Functional responses of human β 1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms. Pharmacogenetics 2004 14 6 343 349 10.1097/00008571-200406000-00003 (Pubitemid 38813688)
107. Tomaszewski M., Brain N. J. R., Charchar F. J., Wang W. Y. S., Lacka B., Padmanabahn S., Clark J. S., Anderson N. H., Edwards H. V., Zukowska- Szczechowska E., Grzeszczak W., Dominiczak A. F., Essential hypertension and β 2-adrenergic receptor gene: linkage and association analysis. Hypertension 2002 40 3 286 291 10.1161/01.HYP.0000029105.21202.FE (Pubitemid 35006712)
108. Green S. A., Turki J., Innis M., Liggett S. B., Amino-terminal polymorphisms of the human β 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994 33 32 9414 9419 2-s2.0-0028068550 (Pubitemid 24272896)
109. Dishy V., Sofowora G. G., Xie H.-G., Kim R. B., Byrne D. W., Michael Stein C., Wood A. J. J., The effect of common polymorphisms of the β 2-adrenergic receptor on agonist-mediated vascular desensitization. The New England Journal of Medicine 2001 345 14 1030 1035 2-s2.0-0035807591 10.1056/NEJMoa010819
110. Gratze G., Fortin J., Labugger R., Binder A., Kotanko P., Timmermann B., Luft F. C., Hoehe M. R., Skrabal F., β -2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999 33 6 1425 1430 2-s2.0-0033017630 (Pubitemid 29282665)
111. Hoit B. D., Suresh D. P., Craft L., Walsh R. A., Liggett S. B., β 2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. American Heart Journal 2000 139 3 537 542 2-s2.0-0033621973
112. Bell C., cbell@cahs.colostate.edu Stob N. R., Seals D. R., Thermogenic responsiveness to nonspecific β -adrenergic stimulation is not related to genetic variation in codon 16 of the β 2-adrenergic receptor. American Journal of Physiology 2006 290 4 E703 E707 10.1152/ajpendo.00411.2005
113. Gjesing A. P., apri@steno.dk Andersen G., Burgdorf K. S., Borch-Johnsen K., Jorgensen T., Hansen T., Pedersen O., Studies of the associations between functional β 2- adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia 2007 50 3 563 568 10.1007/s00125-006-0578-8 (Pubitemid 46215499)
114. Arner P., The β 3-adrenergic receptora cause and cure of obesity? The New England Journal of Medicine 1995 333 6 382 383 2-s2.0-0029084089 10.1056/NEJM199508103330612
115. Enocksson S., Shimizu M., Lonnqvist F., Nordenstrom J., Arner P., Demonstration of an in vivo functional β 3-adrenoceptor in man. Journal of Clinical Investigation 1995 95 5 2239 2245 2-s2.0-0028968883
116. Yang Y. T., McElligott M. A., Multiple actions of β -adrenergic agonists on skeletal muscle and adipose tissue. Biochemical Journal 1989 261 1 1 10 2-s2.0-0024333198 (Pubitemid 19174752)
117. Oizumi T., Daimon M., Saitoh T., Kameda W., Yamaguchi H., Ohnuma H., Igarashi M., Eguchi H., Manaka H., Tominaga M., Kato T., Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the β 3-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 2001 24 9 1579 1583 2-s2.0-0035462465 (Pubitemid 33716452)